Beware of the weasel words of potentially be of significant benefit for people over 45? How weak were the stats that even in a age subset it is still a wishy washy statement IMO
It doesn't even say they spray :will should or would - it say "Could" have clinical benefit in over 45 group?
I hope they can do something with data that is positive so it wasn't just $ pissed against the wall but I'll wait and see as their lack of communication is my biggest red flag and so crazy as I don't believe commenting would disadvantage SPL. It would advantage SPL and markets full understanding of trial results .
Beware of the weasel words of potentially be of significant...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.006(6.06%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $42.85K | 414.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 247015 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |